Hani Rashid, DO
Rheumatology · Scottsdale, AZNPI 1265842389
Payments from drug & device makers
Across 609 payments — averaging $42.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$16K
- AbbVie$3K
- UCB, Inc.$1K
- Johnson & Johnson$1K
- Pfizer$1K
- Lilly USA, LLC$764
- plus $3K from 22 others
What the payments were for
- Food & beverage$12,537100%
- Education$570%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 125 | $16,004 |
| AbbVie | 132 | $2,967 |
| UCB, Inc. | 42 | $1,187 |
| Johnson & Johnson | 59 | $1,162 |
| Pfizer | 67 | $1,101 |
| Lilly USA, LLC | 51 | $764 |
| GSK | 30 | $668 |
| Novartis | 25 | $458 |
| AstraZeneca(2 entities) | 17 | $281 |
| Radius Health, Inc. | 8 | $177 |
| Boehringer Ingelheim | 7 | $150 |
| Genentech USA, Inc. | 6 | $133 |
| Mallinckrodt Hospital Products Inc. | 4 | $116 |
| E.r. Squibb & Sons, L.L.C. | 7 | $116 |
| Sanofi | 5 | $116 |
| Fresenius Kabi USA, LLC | 4 | $88 |
| ANI Pharmaceuticals, Inc. | 3 | $68 |
| Sandoz | 3 | $58 |
| Celltrion USA Inc. | 2 | $41 |
| Aurinia Pharma U.S., Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Ferring Pharmaceuticals Inc. | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Zimmer Biomet | 1 | $27 |
| Bio Products Laboratory USA, Inc. | 1 | $22 |
| Janssen Scientific Affairs, LLC | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,894 in reported general payments places this provider in the 60th percentile of 102 rheumatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 17 | $142,910 |
| Orencia ClickjectAbatacept | 11 | $63,183 |
| MethotrexateMethotrexate Sodium | 183 | $4,343 |
| Leflunomide | 73 | $3,980 |
| Hydroxychloroquine Sulfate | 106 | $3,600 |
| Colchicine | 33 | $2,201 |
| Mycophenolate Mofetil | 16 | $1,258 |
| Prednisone | 120 | $984 |
| Azathioprine | 13 | $783 |
| Folic Acid | 55 | $577 |
| Duloxetine Hcl | 23 | $472 |
| Allopurinol | 55 | $412 |
| Diclofenac Sodium | 17 | $318 |
| Alendronate Sodium | 22 | $213 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $136 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Scottsdale
- Vivek NagarajaScottsdale$306K
- Winford GriffingScottsdale$145K
- Paul HowardScottsdale$124K
- Gary SilvermanScottsdale$109K
- Michael PhamScottsdale$66K
- Ramin SabahiScottsdale$13K
- Gabriel ColceriuScottsdale$13K
- Mark FreijatScottsdale$10K
- Lester MertzScottsdale$4K
- Megan SullivanScottsdale$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.